GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioMedica PLC (OTCPK:OXBDF) » Definitions » Days Sales Outstanding

Oxford BioMedica (Oxford BioMedica) Days Sales Outstanding : 44.03 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Oxford BioMedica Days Sales Outstanding?

Oxford BioMedica's average Accounts Receivable for the six months ended in Dec. 2023 was $14.2 Mil. Oxford BioMedica's Revenue for the six months ended in Dec. 2023 was $58.8 Mil. Hence, Oxford BioMedica's Days Sales Outstanding for the six months ended in Dec. 2023 was 44.03.

The historical rank and industry rank for Oxford BioMedica's Days Sales Outstanding or its related term are showing as below:

OXBDF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 37.26   Med: 68.54   Max: 126.13
Current: 76.87

During the past 13 years, Oxford BioMedica's highest Days Sales Outstanding was 126.13. The lowest was 37.26. And the median was 68.54.

OXBDF's Days Sales Outstanding is ranked worse than
53.48% of 890 companies
in the Biotechnology industry
Industry Median: 72.665 vs OXBDF: 76.87

Oxford BioMedica's Days Sales Outstanding declined from Dec. 2022 (63.56) to Dec. 2023 (44.03).


Oxford BioMedica Days Sales Outstanding Historical Data

The historical data trend for Oxford BioMedica's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioMedica Days Sales Outstanding Chart

Oxford BioMedica Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.76 82.51 63.78 76.35 83.43

Oxford BioMedica Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.39 60.97 63.56 100.14 44.03

Competitive Comparison of Oxford BioMedica's Days Sales Outstanding

For the Biotechnology subindustry, Oxford BioMedica's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioMedica's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioMedica's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Oxford BioMedica's Days Sales Outstanding falls into.



Oxford BioMedica Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Oxford BioMedica's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (41.546 + 10.271) / 2 ) / 113.341*365
=25.9085 / 113.341*365
=83.43

Oxford BioMedica's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (18.12 + 10.271) / 2 ) / 58.833*365 / 2
=14.1955 / 58.833*365 / 2
=44.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford BioMedica  (OTCPK:OXBDF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Oxford BioMedica Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Oxford BioMedica's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioMedica (Oxford BioMedica) Business Description

Traded in Other Exchanges
Address
Windrush Court, Transport Way, Oxford, GBR, OX4 6LT
Oxford BioMedica PLC is a player in the healthcare market in the United Kingdom. As a biopharmaceutical company, it focuses on the field of immunotherapy by managing a platform of technologies for designing gene-based medicines. The company's operating segments include the Platform segment consists of the revenue-generating bioprocessing and process development activities undertaken for third parties. Its Product segment consists of the clinical and preclinical development of in vivo and ex vivo gene and cell therapy products. The company derives the maximum revenue from the Platform segment. Its Platform includes LentiVector, LentiStable, TRiPSystem, SecNuc, Analytics, and others. Geographically, it generates the majority of its revenue from Europe.